Select data courtesy of the U.S. National Library of Medicine.

© 2026 DeepDyve, Inc. All rights reserved.

This site is protected by VikingCloud's Trusted Commerce program

    Comparison of sparfloxacin, temafloxacin, and ciprofloxacin for prophylaxis and treatment of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus

    Cagni, A; Chuard, C; Vaudaux, PE; Schrenzel, J; Lew, DP
    Antimicrobial Agents and Chemotherapy·Aug 1, 1995

    Comparison of sparfloxacin, temafloxacin, and ciprofloxacin for prophylaxis and treatment of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus

    Abstract

    A Cagni, C Chuard, PE Vaudaux, J Schrenzel and DP Lew Division of Infectious Diseases, Geneva University Hospital, Switzerland. The prophylactic and therapeutic activities of three broad-spectrum fluoroquinolones were evaluated in two different experimental models of foreign-body infections caused by methicillin-resistant Staphylococcus aureus (MRSA) susceptible to quinolones. In a guinea pig model of prophylaxis, subcutaneously implanted tissue cages were infected at a > 90% rate by 10(2) CFU of MRSA in control animals. A single dose of 50 mg of ciprofloxacin per kg of body weight administered intraperitoneally 3 h before bacterial challenge was less effective than an equivalent regimen of either sparfloxacin or temafloxacin in decreasing the rate of experimental infection in tissue cages challenged with increasing inocula of MRSA. In a rat model evaluating the therapy of chronic tissue cage infection caused by MRSA, the efficacy of a 7-day high-dose (50-mg/kg twice-daily) regimen of sparfloxacin, temafloxacin, or ciprofloxacin was compared to that of vancomycin (50 mg/kg twice daily). Active levels of sparfloxacin, temfloxacin, or ciprofloxacin were continuously present in tissue cage fluid during therapy, exceeding their MBCs for MRSA by 6- to 20-fold. Either temafloxacin, sparfloxacin, or vancomycin was significantly (P < 0.01) more active than ciprofloxacin in decreasing the viable counts of MRSA in tissue cage fluids. The different activities of ciprofloxacin compared with those of the other two quinolones against chronic tissue cage infections caused by MRSA did not involve the selective emergence of quinolone-resistant mutants. Temafloxacin and ciprofloxacin, which showed the most prominent differences in their in vivo activities, however, exhibited similar bactericidal properties and pharmacokinetic parameters in the rat model.(ABSTRACT TRUNCATED AT 250 WORDS)

    Meet DeepDyve

    Get unlimited, instant access to over 150 million full-text scientific articles for less than the price of buying a single PDF.

    150M+Research Papers
    35M+Full-Text Streaming Papers
    25M+Open Access Papers
    $2/dayStarting Price
    DeepDyve Collection

    DeepDyve Collection

    Access top-tier journals without the top-tier price. We partner directly with the world’s leading academic publishers to bring you legally compliant, instant access. Read the latest findings from Springer, Wiley, Oxford University Press, and more—all in one subscription.

    Browse our collection of titles from leading publishers

    arXiv
    ChemRxiv
    Hindawi
    JAMA
    MDPI
    medRxiv
    NEJM
    Oxford University Press
    PLOS
    PubMed
    Sage
    Springer Nature
    Wiley
    Wolters Kluwer
    AI Research Assistant

    AI Research Assistant

    Accelerate your research with our advanced AI tools. Chat directly with your uploaded papers, and DeepDyve’s 50M+ LitStream and OA collections of full-text papers. AI responses come directly from the literature, footnoted and sourced, to provide the most authoritative and verifiable responses. AI outputs powered by OpenAI and Anthropic Claude. AI Smart Folders (coming soon)

    Stop wasting time on paywalls, pirated sites and scattered journal portals

    Streamline your research workflow with DeepDyve's comprehensive literature management solution for less than the price of buying a single PDF.

    Try 1 month for $0